An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSD
Clinical trial NCT07670702 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07670702
- Sponsor
- Transcend Therapeutics
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-12-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.